Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia

BACKGROUND: Intimal hyperplasia remains the primary cause of vein graft failure for the 1 million yearly bypass procedures performed using human saphenous vein (HSV) grafts. This response to injury is caused in part by the harvest and preparation of the conduit. The use of Brilliant Blue FCF (FCF) r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Vasc Surg
Autori principali: Osgood, Michael J., Sexton, Kevin, Voskresensky, Igor, Hocking, Kyle, Song, Jun, Komalavilas, Padmini, Brophy, Colleen, Cheung-Flynn, Joyce
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480606/
https://ncbi.nlm.nih.gov/pubmed/27763268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2015.02.028
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi